- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/108 - EscherichiaKlebsiella
Patent holdings for IPC class A61K 39/108
Total number of patents in this class: 669
10-year publication summary
|
45
|
35
|
40
|
45
|
50
|
42
|
35
|
51
|
51
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1629 |
53 |
| Janssen Pharmaceuticals, Inc. | 442 |
44 |
| Pfizer Inc. | 3398 |
19 |
| Cornell University | 3369 |
15 |
| Zoetis Services LLC | 1531 |
15 |
| Qu Biologics Inc. | 32 |
14 |
| University of Maryland, Baltimore | 1040 |
14 |
| Sequoia Vaccines, Inc. | 14 |
12 |
| The United States of America as represented by the Secretary of the Navy | 2807 |
10 |
| Scandinavian Biopharma Holding AB | 18 |
10 |
| Northwestern University | 3464 |
8 |
| Board of Trustees of the University of Arkansas | 824 |
7 |
| Idorsia Pharmaceuticals Ltd. | 344 |
7 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 379 |
6 |
| The Texas a & M University System | 1787 |
6 |
| Vaxxinova US, Inc. | 50 |
6 |
| Idemitsu Kosan Co., Ltd. | 4226 |
5 |
| University of Southern California | 2125 |
5 |
| The Administrators of the Tulane Educational Fund | 409 |
5 |
| Intervet Inc. | 905 |
5 |
| Other owners | 403 |